Hepatocellular carcinoma in children with hepatitis B surface antigen. 1992

Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
Department of Pediatrics, Akita University School of Medicine.

This study discusses four children of hepatocellular carcinoma (HCC) who were asymptomatic HBsAg carriers or had HBsAg-positive chronic hepatitis for 3 to 11 years before the occurrence of the carcinoma. Three of these four patients were positive for anti-HBe at 3 to 5 years before the diagnosis of hepatocellular carcinoma. Autopsy findings disclosed liver cirrhosis in all the four patients. To the best of our knowledge few reports have documented children in HBsAg carrier status or with HBsAg-positive hepatitis prior to the development of hepatocellular carcinoma. It is emphasized that HBsAg-positive children, with or without detectable hepatic lesions in routine examinations, have a possibility of developing HCC, and should be carefully monitored for long periods.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
July 1985, Japanese journal of cancer research : Gann,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
November 1983, Acta pathologica japonica,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
January 1982, Indian journal of cancer,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
October 1992, Gastroenterology,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
September 1985, American journal of diseases of children (1960),
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
September 2009, Journal of medical virology,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
December 1979, Virchows Archiv. A, Pathological anatomy and histology,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
January 1978, Gastroenterology,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
January 1995, Princess Takamatsu symposia,
Y Tazawa, and F Nishinomiya, and H Noguchi, and S Tsuchiya, and Y Hayashi, and D Abukawa, and M Watabe, and M Nakagawa, and M Imaizumi, and R Ohi
May 2017, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!